RELMADA THERAPEUTICS, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $1.4M | $4.2M | $2.8M |
| Jun 2017 | $1.4M | $2.8M | $1.7M |
| Sep 2017 | $4.1M | $5.6M | $4.7M |
| Dec 2017 | $5.9M | $6.6M | $5.9M |
| Mar 2018 | $7.1M | $4.8M | $4.3M |
| Jun 2018 | $8.6M | $3.0M | $2.2M |
| Sep 2018 | $10.3M | $1.6M | $887.5K |
| Dec 2018 | $1.9M | $3.3M | $2.4M |
| Mar 2019 | $2.1M | $2.6M | $2.1M |
| Jun 2019 | $2.6M | $10.2M | $9.2M |
| Sep 2019 | $2.5M | $8.5M | $7.8M |
| Dec 2019 | $1.5M | $117.1M | $36.3M |
| Mar 2020 | $2.3M | $115.4M | $12.2M |
| Jun 2020 | $2.3M | $134.6M | $13.8M |
| Sep 2020 | $3.4M | $125.6M | $7.5M |
| Dec 2020 | $12.6M | $118.2M | $2.5M |
| Mar 2021 | $12.7M | $103.9M | $3.8M |
| Jun 2021 | $13.9M | $110.8M | $4.7M |
| Sep 2021 | $18.2M | $90.9M | $11.4M |
| Dec 2021 | $15.1M | $223.3M | $44.4M |
| Mar 2022 | $15.4M | $225.8M | — |
| Jun 2022 | $18.9M | $215.8M | — |
| Sep 2022 | $20.8M | $187.1M | $42.5M |
| Dec 2022 | $12.5M | $152.9M | $5.4M |
| Mar 2023 | $10.1M | $135.6M | $28.9M |
| Jun 2023 | $10.7M | $122.0M | $14.5M |
| Sep 2023 | $8.4M | $109.1M | $6.7M |
| Dec 2023 | $12.2M | $97.6M | $4.1M |
| Mar 2024 | $12.4M | $84.4M | $1.3M |
| Jun 2024 | $9.5M | $71.0M | $2.1M |
| Sep 2024 | $8.1M | $55.7M | $1.5M |
| Dec 2024 | $10.3M | $45.8M | $3.9M |
| Mar 2025 | $5.2M | $27.7M | $1.1M |
| Jun 2025 | $5.2M | $21.1M | $1.4M |
| Sep 2025 | $5.4M | $14.9M | $1.4M |
| Dec 2025 | $7.5M | $94.0M | $3.5M |
| Mar 2026 | $16.6M | $235.4M | $9.8M |
| Jun 2026 | $12.5M | $219.1M | $11.3M |